Month: September 2021

Preliminary findings from ongoing Phase 1 healthy volunteer study will include data relating to mechanism of action; optimal dose; and time to onset, duration and magnitude of pharmacodynamic effects Final data from completed Phase 1b study in patients with small cell lung cancer (SCLC) receiving topotecan supporting best-in-class potential of ALRN-6924BOSTON, Sept. 10, 2021 (GLOBE NEWSWIRE) — Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients, today announced two upcoming poster presentations at the European Society of Medical Oncology (ESMO) Virtual Congress 2021, which is being held September 16-21, 2021. In these posters, Aileron will present preliminary data from its ongoing Phase 1 study of ALRN-6924 in healthy...

TORONTO, Sept. 10, 2021 (GLOBE NEWSWIRE) — CF Energy Corp. (TSX-V:CFY) (“CF Energy” or the “Company”; together with its subsidiaries, the “Group”), a leading new energy service provider in the People’s Republic of China (the “PRC” or “China”), is pleased to announce that the Company’s Haitang Bay Integrated Smart Energy Phase One Project has successfully commenced operation in September of 2021. The first group of commercial customers received the district cooling supply service from the Company includes The Sanya Edition Hotel, Fairmont Sanya Haitang Bay and Westin Sanya Haitang Bay Resort. The DoubleTree Resort by Hilton is also expected to be connected upon its completion of renovations. The collective cooling space of these customers is about 195,040 square meters. The Company has signed up nine commercial customers in Haitang...

SAN CARLOS, Calif., Sept. 10, 2021 (GLOBE NEWSWIRE) — We are advised by Check Point Software Technologies Ltd. that journalists and other readers should disregard the news release, “August 2020’s Most Wanted Malware: Evolved Qbot Trojan Ranks On Top Malware List For First Time” issued September 10, 2021 over GlobeNewswire.

COMPANY ANNOUNCEMENT NO 44/2021 – 10 SEPTEMBER 2021 In continuation of company announcement, no 37/2021, which was published on 1 July 2021, Royal Unibrew is happy to announce that the acquisition of Solera Beverage Group has been approved by the Finnish Competition and Consumer Authority today and that closing of the deal will happen within the next few days. As previously announced, Royal Unibrew has agreed to acquire Solera Beverage Group from the private equity fund, CapMan, at an enterprise value of around DKK 770 million (NOK 1.1 billion) on a debt free basis. Solera Beverage Group has around 150 employees and generates normalized revenue (excluding positive COVID-19 effects) of around DKK 1.3 billion and a normalized EBITDA of around DKK 70 million. Solera Beverage Group is a leading importer and distributor of a strong portfolio...

CORAL GABLES, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases, today announced that Patrick J. McEnany, Catalyst’s Chief Executive Officer and Steven Miller, Ph.D., Chief Scientific Officer /COO, will participate in two upcoming investor conferences:The H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021. Catalyst’s pre-recorded presentation will be available for viewing on-demand beginning Monday, September 13, 2021, at 7:00 AM EDT for those registered for the event. Catalyst’s management will host virtual 1×1 meetings throughout the day.2021 Cantor...

Los Angeles CA, Sept. 10, 2021 (GLOBE NEWSWIRE) — CurrencyWorks Inc. (“CurrencyWorks” or the “Company”), (CSE: CWRK and OTCQB: CWRK), a full service blockchain platform provider, today announced that it will be featured as a presenting company at the H.C. Wainwright 23rd Annual Global Investment Conference. The conference is taking place virtually from September 13-15, 2021. Cameron Chell, Executive Chairman of CurrencyWorks, will provide an overview of the Company’s business during the presentation. If you are an institutional or retail investor, and would like to listen to the Company’s presentation, please click here to register for the conference. The Company’s presentation will be available online starting on September 13th at 7:00 A.M. (ET). It will be archived for 90 days. Dozens of corporate presentations and panels...

TORONTO, Sept. 10, 2021 (GLOBE NEWSWIRE) — WPT Industrial Real Estate Investment Trust (the “REIT”) (TSX: WIR.U; WIR.UN – OTCQX: WPTIF) today announced the mailing of its management information circular (the “Circular”) and related materials for the special meeting (the “Meeting”) of the REIT’s unitholders (the “Unitholders”) to consider the previously announced plan of arrangement (the “Arrangement”) pursuant to which an affiliate of Blackstone Real Estate Income Trust, Inc. would acquire all of the outstanding trust units of the REIT (each, a “Unit”) through a series of transactions that would result in Unitholders receiving US$22.00 per Unit in cash (the “Consideration”), subject to applicable withholdings (the “Transaction”), all as more particularly described in the Circular. Recommendation of the Board of Trustees After...

BOSTON, Sept. 10, 2021 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology company developing novel molecular glue precision medicines, today announced that it will be added to the Russell 2000® and Russell 3000® Indexes as part of second quarter initial public offering additions, effective Sept. 20, 2021. The stock will also be automatically added to the appropriate growth and value indexes. “On the heels of our successful IPO, the addition of Monte Rosa to the Russell 2000 and Russell 3000 Indexes serves as a significant milestone for the company as we advance our pipeline of novel molecular glues and continue the development of our unique and proprietary QuEENTM platform,” said Ajim Tamboli, CFA, Chief Financial Officer. “We are pleased to be part of the Russell indexes and look forward to broadening...

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/ TORONTO, Sept. 10, 2021 (GLOBE NEWSWIRE) —  Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce the filing of the Company’s unaudited interim financial statements for the three- and six-month period ended June 30, 2021, accompanying management’s discussion and analysis and related certifications ‎‎(collectively, the “Documents”) and provides a corporate update. Electronic copies of the Documents are available on SEDAR (www.sedar.com)...

Development of saponin molecules designed to provide high-efficacy and long-lasting protection for pandemic vaccines LEXINGTON, Mass. and BOSTON, Sept. 10, 2021 (GLOBE NEWSWIRE) — Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections today announced the launch of SaponiQx, a subsidiary of Agenus, dedicated to driving innovation in novel adjuvant discovery and vaccine design, and its partnership with Ginkgo Bioworks, Inc. (“Ginkgo”), the leading horizontal platform for cell programming. Ginkgo, which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), is enabling customers across industries to improve products and manufacturing processes,...